Icure Pharmaceutical Inc a biopharmaceutical company in Korea, announced that its donepezil patch, a treatment of Alzheimer’s-type dementia, received a drug product approval from the Ministry of Food and Drug Safety of Korea.
The drug product approval process took 7 months after it filed an application in April 2021. With the approval, Icure marks the first commercialization of the donepezil patch in the world.
- Read more about Icure Acquires Drug Product Approval for World's First Donepezil Patch for Treating Dementia of the Alzheimer Type in Korea
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/icure-acquires-drug-product-approval-for-worlds-first-donepezil-patch-for-treating-dementia-of-the-alzheimer-type-in-korea
No comments:
Post a Comment